Robert P. Castleberry

6.8k total citations · 1 hit paper
75 papers, 4.6k citations indexed

About

Robert P. Castleberry is a scholar working on Neurology, Molecular Biology and Surgery. According to data from OpenAlex, Robert P. Castleberry has authored 75 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Neurology, 28 papers in Molecular Biology and 18 papers in Surgery. Recurrent topics in Robert P. Castleberry's work include Neuroblastoma Research and Treatments (39 papers), Acute Myeloid Leukemia Research (14 papers) and Cancer therapeutics and mechanisms (13 papers). Robert P. Castleberry is often cited by papers focused on Neuroblastoma Research and Treatments (39 papers), Acute Myeloid Leukemia Research (14 papers) and Cancer therapeutics and mechanisms (13 papers). Robert P. Castleberry collaborates with scholars based in United States, Canada and Austria. Robert P. Castleberry's co-authors include Vijay Joshi, Wendy B. London, Katherine K. Matthay, Hiroyuki Shimada, Daniel O. Stram, Susan L. Cohn, Peter D. Emanuel, Robert B. Gerbing, Junichi Hata and Inge M. Ambros and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Robert P. Castleberry

74 papers receiving 4.5k citations

Hit Papers

The International Neuroblastoma Pathology Classification ... 1999 2026 2008 2017 1999 200 400 600

Peers

Robert P. Castleberry
Susan G. Kreissman United States
J Lemerle France
Penelope Brock United Kingdom
Kim Kramer United States
Judith G. Villablanca United States
Brian H. Kushner United States
Robert P. Castleberry
Citations per year, relative to Robert P. Castleberry Robert P. Castleberry (= 1×) peers Dominique Plantaz

Countries citing papers authored by Robert P. Castleberry

Since Specialization
Citations

This map shows the geographic impact of Robert P. Castleberry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert P. Castleberry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert P. Castleberry more than expected).

Fields of papers citing papers by Robert P. Castleberry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert P. Castleberry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert P. Castleberry. The network helps show where Robert P. Castleberry may publish in the future.

Co-authorship network of co-authors of Robert P. Castleberry

This figure shows the co-authorship network connecting the top 25 collaborators of Robert P. Castleberry. A scholar is included among the top collaborators of Robert P. Castleberry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert P. Castleberry. Robert P. Castleberry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Braunstein, Steve, Wendy B. London, Susan G. Kreissman, et al.. (2019). Role of the extent of prophylactic regional lymph node radiotherapy on survival in high‐risk neuroblastoma: A report from the COG A3973 study. Pediatric Blood & Cancer. 66(7). e27736–e27736. 9 indexed citations
2.
Schneiderman, Jennifer, Wendy B. London, Garrett M. Brodeur, et al.. (2008). Clinical Significance of MYCN Amplification and Ploidy in Favorable-Stage Neuroblastoma: A Report From the Children's Oncology Group. Journal of Clinical Oncology. 26(6). 913–918. 50 indexed citations
3.
Zage, Peter E., Morris Kletzel, Kevin Murray, et al.. (2008). Outcomes of the POG 9340/9341/9342 trials for children with high‐risk neuroblastoma: A report from the Children's Oncology Group. Pediatric Blood & Cancer. 51(6). 747–753. 66 indexed citations
4.
Friedman, Gregory K. & Robert P. Castleberry. (2007). Changing trends of research and treatment in infant neuroblastoma. Pediatric Blood & Cancer. 49(S7). 1060–1065. 24 indexed citations
5.
Bagatell, Rochelle, Wendy B. London, Susan L. Cohn, et al.. (2005). Outcomes of Children With Intermediate-Risk Neuroblastoma After Treatment Stratified by MYCN Status and Tumor Cell Ploidy. Journal of Clinical Oncology. 23(34). 8819–8827. 59 indexed citations
6.
Rodríguez‐Galindo, Carlos, Marcia M. Wofford, Robert P. Castleberry, et al.. (2005). Preradiation chemotherapy with methotrexate, cisplatin, 5‐fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma. Cancer. 103(4). 850–857. 64 indexed citations
7.
Zebrack, Brad, James G. Gurney, Kevin C. Oeffinger, et al.. (2004). Psychological Outcomes in Long-Term Survivors of Childhood Brain Cancer: A Report From the Childhood Cancer Survivor Study. Journal of Clinical Oncology. 22(6). 999–1006. 306 indexed citations
8.
Katzenstein, Howard M., Mark Krailo, Marcio H. Malogolowkin, et al.. (2003). Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer. 97(8). 2006–2012. 112 indexed citations
9.
London, Wendy B., A. Thomas Look, Garrett M. Brodeur, et al.. (2000). Natural History and Biology of Stage A Neuroblastoma: A Pediatric Oncology Group Study. ˜The œAmerican journal of pediatric hematology/oncology. 22(3). 197–205. 70 indexed citations
10.
Cushing, Barbara, Roger Giller, Arthur R. Ablin, et al.. (2000). Surgical Resection Alone Is Effective Treatment for Ovarian Immature Teratoma in Children and Adolescents: A Report of the Pediatric Oncology Group and the Children’s Cancer Group. Obstetrical & Gynecological Survey. 55(1). 29–29. 4 indexed citations
11.
Perlman, Elizabeth J., Jie Hu, Deborah Ho, et al.. (2000). Genetic Analysis of Childhood Endodermal Sinus Tumors by Comparative Genomic Hybridization. ˜The œAmerican journal of pediatric hematology/oncology. 22(2). 100–105. 53 indexed citations
12.
Smith, E. Ide, et al.. (1999). Lymph node sampling in localized neuroblastoma: A Pediatric Oncology Group study. Journal of Pediatric Surgery. 34(6). 967–974. 5 indexed citations
13.
Gladson, Candece L., Susan M. Hancock, Muoi Arnold, et al.. (1996). Stage-specific expression of integrin alphaVbeta3 in neuroblastic tumors.. Europe PMC (PubMed Central). 148(5). 1423–34. 35 indexed citations
14.
Hess, Jay L., Mary M. Zutter, Robert P. Castleberry, & Peter D. Emanuel. (1996). Juvenile Chronic Myelogenous Leukemia. American Journal of Clinical Pathology. 105(2). 238–248. 19 indexed citations
15.
Morris, Jonathan, Stephen J. Shochat, E. Ide Smith, et al.. (1995). Biological variables in thoracic neuroblastoma: A Pediatric Oncology Group study. Journal of Pediatric Surgery. 30(2). 296–303. 33 indexed citations
17.
Shuster, Jonathan J., Nancy B. McWilliams, Robert P. Castleberry, et al.. (1992). Serum Lactate Dehydrogenase in Childhood Neuroblastoma A Pediatric Oncology Group Recursive Partitioning Study. American Journal of Clinical Oncology. 15(4). 295–303. 57 indexed citations
19.
McConnell, Michael E., Joycelyn Atchison, Edward C. Kohaut, & Robert P. Castleberry. (1987). Successful Use of Plasma Exchange in a Child with Refractory Immune Hemolytic Anemia. Journal of Pediatric Hematology/Oncology. 9(2). 158–160. 4 indexed citations
20.
Holbrook, C. Tate, Frederick J. Elsas, William M. Crist, & Robert P. Castleberry. (1978). Acute leukemia and hypopyon. The Journal of Pediatrics. 93(4). 626–628. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026